Avanos to Be Acquired by AIP in $1.27B Deal
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
NEWPORT BEACH, Calif., March 3, 2026 Investment firm NorthStrive Fund II LP has called on enVVeno Medical Corporation to...
NEW YORK, Feb. 24, 2026 — Bristol Myers Squibb announced its participation in the upcoming TD Cowen 46th Annual...
HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...
Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...
